Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium.

Mai PL, Malkin D, Garber JE, Schiffman JD, Weitzel JN, Strong LC, Wyss O, Locke L, Means V, Achatz MI, Hainaut P, Frebourg T, Evans DG, Bleiker E, Patenaude A, Schneider K, Wilfond B, Peters JA, Hwang PM, Ford J, Tabori U, Ognjanovic S, Dennis PA, Wentzensen IM, Greene MH, Fraumeni JF Jr, Savage SA.

Cancer Genet. 2012 Oct;205(10):479-87. doi: 10.1016/j.cancergen.2012.06.008. Epub 2012 Aug 29.

2.

Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.

Kamihara J, Rana HQ, Garber JE.

Hum Mutat. 2014 Jun;35(6):654-62. doi: 10.1002/humu.22559. Review.

PMID:
24706533
3.

Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician.

Giacomazzi CR, Giacomazzi J, Netto CB, Santos-Silva P, Selistre SG, Maia AL, Oliveira VZ, Camey SA, Goldim JR, Ashton-Prolla P.

Rev Assoc Med Bras (1992). 2015 May-Jun;61(3):282-9. doi: 10.1590/1806-9282.61.03.282. Review.

4.

[Li-Fraumeni syndrome].

Tsunematsu Y.

Nihon Rinsho. 2000 Jul;58(7):1442-7. Review. Japanese.

PMID:
10921321
5.

Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.

Sorrell AD, Espenschied CR, Culver JO, Weitzel JN.

Mol Diagn Ther. 2013 Feb;17(1):31-47. doi: 10.1007/s40291-013-0020-0. Review.

6.

[Li-Fraumeni syndrome: update, new data and guidelines for clinical management].

Frebourg T, Abel A, Bonaiti-Pellie C, Brugières L, Berthet P, Bressac-de Paillerets B, Chevrier A, Chompret A, Cohen-Haguenauer O, Delattre O, Feingold J, Feunteun J, Frappaz D, Fricker JP, Gesta P, Jonveaux P, Kalifa C, Lasset C, Leheup B, Limacher JM, Longy M, Nogues C, Oppenheim D, Sommelet D, Soubrier F, Stoll C, Stoppa-Lyonnet D, Tristant H.

Bull Cancer. 2001 Jun;88(6):581-7. Review. French.

7.

The Li-Fraumeni syndrome: an inherited susceptibility to cancer.

Evans SC, Lozano G.

Mol Med Today. 1997 Sep;3(9):390-5. Review.

PMID:
9302689
8.

Germline TP53 mutations and Li-Fraumeni syndrome.

Varley JM.

Hum Mutat. 2003 Mar;21(3):313-20. Review. Erratum in: Hum Mutat. 2003 May;21(5):551.

PMID:
12619118
9.

Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome.

Palmero EI, Achatz MI, Ashton-Prolla P, Olivier M, Hainaut P.

Curr Opin Oncol. 2010 Jan;22(1):64-9. doi: 10.1097/CCO.0b013e328333bf00. Review.

PMID:
19952748
10.

[Li-Fraumeni syndrome].

Frebourg T.

Bull Cancer. 1997 Jul;84(7):735-40. Review. French.

11.

Late onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature.

Kast K, Krause M, Schuler M, Friedrich K, Thamm B, Bier A, Distler W, Krüger S.

BMC Cancer. 2012 Jun 6;12:217. doi: 10.1186/1471-2407-12-217. Review.

12.

Li-Fraumeni syndrome: cancer risk assessment and clinical management.

McBride KA, Ballinger ML, Killick E, Kirk J, Tattersall MH, Eeles RA, Thomas DM, Mitchell G.

Nat Rev Clin Oncol. 2014 May;11(5):260-71. doi: 10.1038/nrclinonc.2014.41. Epub 2014 Mar 18. Review.

PMID:
24642672
13.

[Li-Fraumeni syndrome: clinico-molecular diagnostics and medico-genetic counseling].

Liubchenko LN.

Vestn Ross Akad Med Nauk. 2011;(12):47-52. Review. Russian.

PMID:
22379889
14.

EFGR-mutant lung adenocarcinoma and Li-Fraumeni syndrome: report of two cases and review of the literature.

Ricordel C, Labalette-Tiercin M, Lespagnol A, Kerjouan M, Dugast C, Mosser J, Desrues B, Léna H.

Lung Cancer. 2015 Jan;87(1):80-4. doi: 10.1016/j.lungcan.2014.11.005. Epub 2014 Nov 20. Review.

PMID:
25433984
15.

Germline mutations in the TP53 gene.

Eeles RA.

Cancer Surv. 1995;25:101-24. Review.

PMID:
8718514
16.

[Li-Fraumeni syndrome].

Tokunaga A, Onda M, Matsukura N, Kato S.

Nihon Rinsho. 1995 Nov;53(11):2797-802. Review. Japanese.

PMID:
8538047
17.

[Li-Fraumeni syndrome and germ-line mutations of the p53 gene].

Leblanc T, Soussi T.

Arch Pediatr. 1994 Jan;1(1):61-70. Review. French.

PMID:
8087224
18.

[Germline mutations of the p53 gene].

Frebourg T.

Pathol Biol (Paris). 1997 Dec;45(10):845-51. Review. French.

PMID:
9769948
19.

Li-Fraumeni syndrome: the genetics and treatment considerations for the sarcoma and associated neoplasms.

Upton B, Chu Q, Li BD.

Surg Oncol Clin N Am. 2009 Jan;18(1):145-56, ix. doi: 10.1016/j.soc.2008.08.006. Review.

PMID:
19056046
20.

Surveillance recommendations for patients with germline TP53 mutations.

Ballinger ML, Mitchell G, Thomas DM.

Curr Opin Oncol. 2015 Jul;27(4):332-7. doi: 10.1097/CCO.0000000000000200. Review.

PMID:
26049273

Supplemental Content

Support Center